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Abstract Trichomonas vaginalis causes the most common
non-viral sexually transmitted infection linked to increased
risk of premature birth, cervical cancer and HIV. This study
defines molecular domains of the parasite surface glyco-
conjugate lipophosphoglycan (LPG) with distinct functions
in the host immunoinflammatory response. The ceramide
phospho-inositol glycan core (CPI-GC) released by mild
acid had Mr of ∼8,700 Da determined by MALDI-TOF
MS. Rha, GlcN, Gal and Xyl and small amounts of GalN
and Glc were found in CPI-GC. N-acetyllactosamine
repeats were identified by endo-β-galactosidase treatment
followed by MALDI-MS and MS/MS and capLC/ESI-MS/
MS analyses. Mild acid hydrolysis led to products rich in
internal deoxyhexose residues. The CPI-GC induced
chemokine production, NF-κB and extracellular signal-
regulated kinase (ERK)1/2 activation in human cervicova-
ginal epithelial cells, but neither the released saccharide
components nor the lipid-devoid LPG showed these
activities. These results suggest a dominant role for CPI-
GC in the pathogenic epithelial response to trichomoniasis.
Keywords Trichomonad LPG .Mass spectrometry .
Cytokines . NF-κB . ERK . Vaginal mucosal immunity
Abbreviations






FT MS Fourier transform ion cyclotron resonance
mass spectrometry








matrix-assisted laser desorption ionization/
time-of-flight mass spectrometry
NMR nuclear magnetic resonance




QoTOF quadrupole orthogonal time-of-flight





Glycoconj J (2009) 26:3–17
DOI 10.1007/s10719-008-9157-1
B. N. Singh :G. R. Hayes : J. J. Lucas
Department of Biochemistry and Molecular Biology,
SUNY Upstate Medical University,
750 E Adams St, Syracuse, NY 13210, USA
U. Sommer :N. Viseux : E. Mirgorodskaya :C. E. Costello
Center for Biomedical Mass Spectrometry,
Boston University School of Medicine,
670 Albany St., Rm 511, Boston, MA 02118, USA
R. T. Trifonova : R. R. S. Sassi :R. N. Fichorova (*)
Laboratory of Genital Tract Biology,
Department of Obstetrics, Gynecology and Reproductive Biology,
Brigham and Women’s Hospital, Harvard Medical School,
221 Longwood Ave RF468, Boston, MA 02115, USA
e-mail: rfichorova@rics.bwh.harvard.edu
Introduction
Trichomonas vaginalis is an extracellular parasitic protozoan
that causes one of the most common non-viral sexually
transmitted infections, human trichomoniasis. Each year,
over 180 million people are infected worldwide, including
8–10 million Americans [1–4]. Around the globe, infection
rates have been reported to be as high as 67% in Mongolia
[5], more than 60% in Africa, and 40% in indigenous
Australian women [6]. T. vaginalis adheres to and damages
vaginal epithelial cells [7, 8] and lives in the vagina of
women and the urethra of men. In men, the infection is
usually asymptomatic and self-limiting, although there may
be an irritating urethritis or prostatitis [9, 10]. In women,
the infection causes a wide range of inflammatory symp-
toms and has major health, economic and social conse-
quences including preterm delivery, low birth weight,
transmission of the parasite to newborn girls during
delivery, infertility, cervical cancer and enhanced transmis-
sion rate of HIV [1, 4, 11–13].
The T. vaginalis virulence factors responsible for the
remarkable evasion of the host immunity and the severity of
the pathologic inflammatory reaction in trichomoniasis
remain elusive. Although women may develop specific
antibodies to T. vaginalis antigens, the infections do not
provide lasting immunity, and reinfection is common [1, 4].
Undefined phenotypic variations, release of proteases and
other unknown factors have been attributed to the chronic
nature and re-incidence of infections [1, 14], as well as the
host inflammatory responses during infection [15, 16]. In
other parasitic protozoa, cell surface glycoconjugates, e.g.,
glycolipids, glycoproteins, and glycosylated phosphatidyl
inositol (GPI) glycolipids have been implicated in cell
adhesion, host cell invasion and evasion of host immune
responses [17–20]. The importance of carbohydrate moie-
ties in the pathogenesis of trichomoniasis is suggested by
earlier studies showing that pretreatment of trichomonads
with periodate abolishes the adhesion of parasites to their
respective host cells [7, 21]. We isolated and partially
characterized T. vaginalis lipophosphoglycan (LPG) and
obtained evidence for its essential role in the parasite
adherence and the proinflammatory activation of epithelial
cells from all three distinct anatomic compartments of the
lower human female genital tract—endocervix, ectocervix
and vagina [22].
LPG is the most abundant glycosylated molecule in the
pathogenic trichomonads T. vaginalis and Tritrichomonas
foetus (2–3×106 copies/parasite). T. foetus causes bovine
trichomoniasis; this represents the only animal model for
human trichomoniasis. T. vaginalis and T. foetus LPGs are
anchored on the cell surface via a phospho-inositol
ceramide (CPI) [23, 24]. LPG contains mostly carbohydrate
and the lipid component, and is devoid of any peptide [22,
24, 25]. To a certain extent, trichomonad LPGs are
analogous to the LPGs from other parasites, but the
T. vaginalis and T. foetus LPGs are clearly distinct from
them in their monosaccharide compositions and other
structural features [22, 26, 27]. Unlike the LPG from
Leishmania (which has distinct promastigote and amasti-
gote stages), the LPGs from trichomonads (which have
only one stage) do not undergo structural modifications
during parasite development. Furthermore, unlike the
previously described GPI-anchored molecules, TV-LPG
contains no mannose and our earlier data has suggested
the presence of the phospho-inositol linked ceramide [23,
24] and poly-N-acetyllactosamine repeats (Galβ1–
4GlcNAc) in the LPG molecule [22, 26]. We previously
demonstrated that trichomonad LPGs are involved in the
adhesion of parasites to their respective host cells in a
species-specific manner, a behavior which may be related to
the unique monosaccharide compositions of T. vaginalis
and T. foetus LPGs [21, 22]. Bastida-Corcuera et al. [28]
produced T. vaginalis mutants defective in LPG and
showed that these mutants have reduced adherence and
cytotoxicity to cervical epithelial cells, confirming our own
biochemical observations [21, 22].
Along with the partial compositional characterization of
T. vaginalis LPG, we recently reported the first evidence for
TV-LPG’s role in triggering a selective and species-specific
production of cytokines by human female genital tract
epithelial cells [22]. Here we further define the biochemical
nature of T. vaginalis LPG and determine the specific
molecular domain required for triggering immunoinflam-
matory pathways in human vaginal and cervical epithelia.
Materials and methods
Parasites and LPG
T. vaginalis isolates (UR1) obtained from a symptomatic
patient were cultured in Diamond’s modified media (pH
6.0) with 10% heat-inactivated horse serum (HyClone
Laboratory) at 37°C, as reported earlier [7]. Parasites were
harvested in late log phase (24 h) by centrifugation and
washed twice with phosphate-buffered saline (PBS, pH 7.4)
and suspended in methanol/chloroform (1:2) followed by
extraction of the LPG with solvent E [23]. LPGs from
T. vaginalis and T. foetus were isolated and purified on an
octyl-Sepharose column as previously described [23].
Generation of saccharides and ceramide phospho-inositol
glycan core (CPI-GC) fractions of LPG
LPG was digested by various chemical and enzymatic
treatments and the resultant sub-domains presented sche-
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matically in Fig. 1 were purified and characterized as
described below.
Mild acid-released fractions LPG was hydrolyzed with
100 mM TFA containing DTT (1 mg/mL) at 100°C for 3 h,
under a N2 atmosphere. The resultant sample was dried with
2-propanol and resuspended in a small volume of 0.1%
TFA. The sample was placed on a C18 Sep-Pak® column
(Waters Corp., Milford, MA, USA). Saccharides (outer
branch) were eluted with 0.1% TFA and the CPI-GC was
eluted sequentially with 30%, 50%, and 70% n-propanol.
Aliquots from the outer branch saccharide fraction and the
CPI-GC fraction were dried and later used to stimulate
human cervicovaginal epithelial cells, as described below.
Additional aliquots of the same fractions were dried and
used for monosaccharide and MS analyses. SDS-PAGE
followed by PAS staining was used to verify the release of
the CPI-GC from LPG. For monosaccharide composition
analysis, aliquots of the outer branch saccharide and
CPI-GC fractions were hydrolyzed with 4 M TFA at 125°C
for 1 h and the monosaccharides were separated and quantified
on a PA1 column (Dionex Corp., Sunnyvale, CA, USA) by
HPAE-PAD as reported earlier [22]. The CPI-GC fraction
released by TFA treatment is referred to later as “native”
CPI-GC in contrast to “post-enzymatic” CPI-GC derived by
endo-β-galactosidase digestion of “native” CPI-GC.
Glycosidase treatment “Native” CPI-GC was treated with
β-galactosidase (Jack bean), β-N-acetylhexosaminidase
(Jack bean), and endo-β-galactosidase (Bacteroides fragilis)
which were purchased from Oxford Glyco Systems
(Oxford, UK). In a few experiments, endo-β-galactosidase
(Escherichia freundii) was also obtained from Seikagaku
Corp. (Tokyo, Japan; Associates of Cape Cod, Inc., East
Falmouth, MA, USA). The incubation conditions recom-
mended by the manufacturers were employed in a total
volume of 0.2 mL. The released saccharide(s) and the “post-
enzymatic” CPI-GC (glycan lipid core) were separated on a
C18 Sep-Pak as described above. The saccharides were
labeled with the fluorophore, 8-aminonapthalene-1,3,
6-trisulfonic acid (ANTS), and subjected to Glyko-FACE
analysis for sequencing, as described by the manufacturer.
Selected individual bands were cut and purified by elution
from the gel slices in H2O and re-analyzed. The monosac-
charide compositions of the released fractions were quan-
tified by HPAE-PAD. Individual saccharide fractions
were further analyzed by MALDI-TOF MS, MALDI-FTMS
and LC/MS/MS.
The endo-β-galactosidase released saccharide fraction and
the post-enzymatic CPI-GC fraction were used to stimulate
human cervicovaginal epithelial cells as described below.
The following two enzymes were used to examine the
release of Rha or Xyl from native LPG, CPI-GC and the
mild acid released saccharide fractions: (1) rhamnosidase B
from Bacillus Sp (specific for releasing terminal α-L(+)
Rha from rhamnosyl disaccharides) obtained from Dr. K.
Murata (Kyoto University, Japan) [29]; and (2) β-D-
xylosidase from Selenomonas ruminatium (which catalyzes
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Fig. 1 Schematic of
T. vaginalis LPG showing the
major breakdown products
e.g. outer saccharide branch
and ceramide phospho-inositol
glycan core (CPI-GC) cleaved
by mild TFA hydrolysis
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the hydrolysis of the β1–4 linkage of long polymers of
xylose) kindly provided by Dr. D. B. Jordan (USDA, ARS,
IL, USA) [30].
PI-PLC treatment of LPG To separate the lipid moiety from
the oligosaccharide-inositol-phosphate core (saccharide-I-P)
as previously shown [23, 24], intact LPG was treated with
PI-PLC from Bacillus thuringiensis (obtained from PRO-
zyme Corp., San Leandro, CA, USA) per the manufac-
turer’s instructions for 20 h at 37°C. After the reaction was
stopped with hot ethanol, the solution (which contained the
complete non-lipoid saccharide) was dried and placed on
C18 Sep-Pak and eluted with 0.1% TFA. The eluant which
contained the oligosaccharide-I-P, i.e., the LPG devoid of
the ceramide moiety, was collected and dried and was later
subjected to functional analysis in stimulation of cervico-
vaginal epithelial cells, as described below.
Periodate treatment Intact LPG was treated with periodate
(10 mM) in sodium acetate buffer pH 4.5 for 4 h, as
described [7, 21] and the reaction was stopped by the
addition of excess glycerol to destroy unreacted periodate.
The reaction mixture was dried and dissolved in 0.1% TFA.
It was further purified on a C18 Sep-Pak column and the
lipid-containing fraction that was eluted with n-propanol
(30–70%) was collected and examined to determine its
effect in upregulation of cytokines in our experimental
human cell model.
Mass spectrometry
CPI-GC The mass of the native CPI-GC was determined
by matrix-assisted laser desorption/ionization time-of-flight
mass spectrometry (MALDI-TOF MS) on a Reflex IV mass
spectrometer (Bruker Corp., Billerica, MA, USA), using a
UV laser (337 nm, 3-ns pulse width) and 2,5-dihydrox-
ybenzoic acid as the matrix for analysis of samples
deposited on a stainless steel target. The data were acquired
using Flexcontrol, and were displayed using MoverZ
freeware (Proteometrics, LLC; now within Genomic Sol-
utions, Ann Arbor, MI, USA).
Glycans The sugars released by mild acid or enzymes, were
analyzed (without derivatization) by MALDI-TOF MS
and PSD of the positive ions on a Vision 2000 reflectron
TOF MS [Finnigan Corp. (now Thermo-Fisher Scientific),
Bremen, Germany] [31] and also by MALDI-FT MS
with SORI-CID on an Ion-Spec system (IonSpec Corp.,
Irvine, CA, USA; now Varian FTMS, Lake Forest, CA,
USA), with an external MALDI source and a 7-T actively
shielded magnet. For both types of MALDI-MS analysis,
the matrix was 2,5-DHB. FTMS data are displayed using
the BUDA open source software developed by P. B.
O’Connor at Boston University Center for Biomedical
Mass Spectrometry and available on its websites (www.
busm.bu.edu/msr and www.busm.bu.edu/cardiovascularpro
teomics).
To increase sensitivity and provide more informative
fragmentation, the released glycans were permethylated
[31, 32] and further characterized by MALDI-TOF MS, and
MALDI-FTMS. For both types of MALDI analysis of the
permethylated glycans, 2,5-DHB was used as the matrix. In
later experiments, nanospray MS/MS, or capLC-MS/MS
was employed for samples that were reduced with sodium
borohydride (to avoid chromatographic separation into two
anomeric forms) then purified with a HyperSEP Hypercarb
column (Thermo-Fisher Scientific, Waltham, MA, USA)
and permethylated. These derivatized glycans were ana-
lyzed online with a QStar Pulsar i QoTOF (quadrupole
orthogonal time-of-flight) MS (Applied Biosystems/Sciex,
Toronto, ON, Canada), using protocols we have described
recently [32]. Samples were introduced via self-pulled
glass-tips, or Thermo Hypersil–Keystone porous graphite
chromatography (PGC) columns (2.1×50 mm) on a turbo
spray ion source, and QAnalyst software [32]. Tandem MS
experiments were performed on [M+H]+ and [M + Na]+
ions; several runs were repeated, excluding values up to m/z
900 from independent data acquisition to avoid solvent
clusters. For LC/MS experiments, the flow rate through the
analytical column was maintained at 30 μL/min through
stepwise gradients of different lengths, ranging from 30% B
to 100% B (A: 0.1% formic acid in water; B: 0.1% formic
acid in acetonitrile/isopropanol 1:1) and an after-column
syringe feed of 2 mL/min of 5% formic acid was employed.
MS/MS spectra were interpreted using QAnalyst software
and a self-made calculation table for reduced and perme-
thylated glycans.
Epithelial cell lines and treatment protocols
Well established immortalized human vaginal, ectocervical
and endocervical epithelial cell lines [22, 33–40], were
grown in keratinocyte serum-free medium supplemented
with 50 μg/mL bovine pituitary extract, 0.1 ng/mL
epidermal growth factor, penicillin/streptomycin, and CaCl2
as described [33]. All cell culture reagents were purchased
from Invitrogen (Carlsbad, CA, USA). The cell lines have
been derived from normal endocervical, ectocervical, and
vaginal epithelium and closely represent the phenotypes of
their tissues of origin [33]. These cell lines produce
distinctive repertoires of immunological mediators under
basal, as well as stimulated conditions, in the absence of
TLR4 expression [37] and maintain closely the phenotypic
characteristics of their tissues of origin [40]. They have
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been widely employed as in vitro models for studying
cervical/vaginal physiology and infection [28, 34, 37–39,
41–44].
Confluent cell monolayers in 96-well plates were
exposed to escalating doses of LPG, equivalent doses of
LPG sub-domain fractions and live T. vaginalis for indicated
period of time. Recombinant human IL-1β (R&D Systems,
Minneapolis, MN, USA) served as a positive control for
epithelial proinflammatory activation. Nontoxic experimen-
tal doses of LPG were selected based on MTT viability
assays and ranged from 500 to 15 μg/mL. These doses were
equivalent to 2.5×107–0.8×106 parasites/mL, or about 10−1
parasites/epithelial cell in our experimental model, which
approximates parasite load during trichomonad infection
[22]. The concentration of each LPG fraction was normal-
ized based on the known amount of LPG used for the
isolation of this fraction. At the end of each stimulation
period, cell culture supernatants were collected for cyto-
kines, and the cells were used for MTT viability assay
(Promega, Madison, WI, USA) as described in detail
elsewhere [22] or were lysed for total protein assessment
by BCA assay (Pierce, Rockford, IL, USA) and phospho-
protein analysis.
Endotoxin measurement
Endotoxin contamination of LPG and LPG fractions was
ruled out using the EndoSafe Test System (Charles River
Laboratories, Charleston, SC, USA) based on the Limulus
Amoebocyte Lysate test [45] with sensitivity <0.05 EU/mL.
A negative control and the recovery of a known amount of
endotoxin spike are inherent in each sample testing in this
system. Each sample was tested in quadruplicate with a
coefficient of variation <10%.
Measurement of inflammatory mediators
and phosphoproteins
Electrochemiluminescence (ECL) immunoassays and Imager
2400 (both from Meso Scale Discovery, Gaithersburg,
MD, USA) determinations were used to measure IL-8 in
cell culture supernatants and phosphoproteins in cell
lysates, as previously described [22, 46]. For IL-8 analysis,
epithelial cells were stimulated for 24 h. For protein
phosphorylation analysis, epithelial cells were stimulated
for 30–90 min, then rinsed with ice-cold PBS containing
1 mM Na3VO4 (Sigma, St. Louis, MO, USA) and lysed in
20 mM Tris lysis buffer (100 μL lysate per 105 cells),
containing the phosphatase inhibitors 2 mM PMSF and
0.01M NaF (Sigma) and Roche protease inhibitor cocktail
(Fisher). The lysates were normalized to total protein
concentration measured by BCA assay prior to analysis
for phospho (p) extracellular signal-regulated ERK1/2 (Thr/
Tyr: 202/204; 185/187), pNF-κB/p65 (Ser538) and pMEK
(MAPK/ERK) 1 and 2 (Ser217/221).
Activation of nuclear factor (NF)-κB
The endocervical epithelial cell line End1/E6E7 was stably
transfected with pHTS-NFκB firefly luciferase reporter vector
(Biomyx Technology, San Diego, CA, USA) using the gene-
juice transfection method [22] and hygromycin selection
(Biomyx). The reporter cell line was seeded at 1×105 cells/
mL in 96-well plates and treated as described above. At the
end of each stimulation period, cells were washed with
PBS, lysed in Glo lysis buffer 0.1 mL/well and luciferase
activity was measured using the Bright-Glo Luciferase Assay
System per the manufacturer’s instructions (Promega). The
luminescence signal was read using Victor2 1420 multilabel
microplate counter with Wallac software 2.01 (Perkin Elmer
Life Sciences, Waltham, MA, USA).
Statistical analysis
One-way ANOVA with Dunnett’s Bonferroni’s multiple
comparison tests or t-test analysis was performed using
GraphPad Prism 4 (GraphPad Software, San Diego, CA,
USA). P values <0.05 were considered significant.
Results
Structural features of the LPG fragment
Previous data indicated the presence of terminal β1– 4-linked
Gal residue(s) [47] in the T. vaginalis LPG structure, based
on lectin RCA-1 binding to intact LPG [47]. Because of the
complexity of LPG, its polydisperse nature and the unusual
monosaccharide compositions [22], we designed a strategy
to separate outer-carbohydrate and glycan-lipid sub-
domains to further study their composition and functional
importance. Figure 1 shows a schematic summary of current
knowledge of the complex LPG molecule, representing the
generation of various fragments and their compositions.
The fraction referred to as the outer branch in Fig. 1 was
released by mild acid treatment, as reported for Leishmania
LPGs [17–19]. The nature of linkage between the outer
branch saccharide fraction and the CPI-GC that is cleaved
by mild TFA is not known at this point. So far, the
hydrolysis observed upon treatment with mild acid,
indicates that phosphate linkage(s) connect the CPI-GC
core and the TFA released fractions; the possible presence
of other types of linkages is still under investigation.
Glyko-FACE analysis of this outer-branch fraction revealed
several saccharide fragments equivalent to a size range of 2
to more than 20 standard glucose units (data not shown).
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This fraction was biologically inert, as shown below
(Figs. 8, 9 and 10).
Individual treatments of intact TV-LPG with the exogly-
cosidases, β-galactosidase and β-N-acetylhexosaminidase
resulted in release of Gal and GlcNAc, respectively,
suggesting the presence of terminal β-Gal and β-GlcNAc.
Release of these residues was verified by HPAE-PAD
analysis. No monosaccharides were released from the intact
LPG by treatment with any of the other glycosidases tested,
including rhamnosidase and xylosidase.
Incubation of intact LPG with endo-β-galactosidase
resulted in the release of four to five oligosaccharide
fragments ranging in size from 2.8 glucose units to 6
glucose units as determined by Glyko-FACE analysis
(Fig. 2). The band migrating at ∼3.5 glucose units (Fig. 2,
band B) contained saccharides with terminal GlcNAc while
the band at ∼2.8 glucose units contained terminal Gal.
These data suggest that endo-β-galactosidase-released
saccharides contain repeating lactosamine structures. The
presence of poly-N-acetyllactosamine repeats was con-
firmed by MS analyses described below.
Mass spectral analyses of the saccharides released from
intact LPG treated with endo-β-galactosidase indicated a
wide range of heterogeneity and different degrees of glycan
release (Figs. 3 and 4), whereas hydrolysis of LPG with
mild TFA led to a diverse array of compounds, including
free oligosaccharides. With either MALDI or ESI, the
sequence of acid- and/or glycosidase-released glycan
fractions could be clearly read from the MS/MS spectra,
as demonstrated by the PSD spectrum (Fig. 3b) resulting
from metastable decomposition of the [M + Na]+ ions that
appear at m/z 771 in the MALDI-TOF mass spectrum
(Fig. 3a), of a saccharide released by endo-β-galactosidase
treatment of intact LPG and in the ESI-CID QoTOF mass
spectra of saccharides released by glycosidase or mild acid
treatment of LPG, as shown in Figs. 4a and b, respectively.
The MALDI-FTMS results (e.g., Fig. 5 and Table 1)
indicated that other oligosaccharides were rich in dHex
(likely Rha based on monosaccharide analysis). Assign-
ments for additional ions analyzed by MS/MS are underway.
The MALDI-TOF mass spectrum of the endo-β-galac-
tosidase released glycans (Fig. 3a) had peaks at m/z 406,
568, 771, 933, 1,136 corresponding to the [M + Na]+ of
HexHexNAc, HexHexNAcHex, (HexNAcHex)2, (HexHex-
NAc)2Hex and higher members of the series. The sequen-
ces of the glycan residues could be determined from the
post-source decay spectra (e.g., Fig. 3b). Post-source decay
results in only glycosidic cleavages, and therefore the order
of the residues can be determined, but information on the
linkage sites is not available. Treatment with β-N-acetyl
hexosaminidase changed the MALDI mass spectrum shown
in the top panel to a simpler series (Fig. 3c) having peaks at
365-u intervals that correspond to HexHexNAc (likely
N-acetyllactosamine multimers), at m/z 538, 933, 1,298,
etc. The presence of glycan regions having extended
N-acetyllactosamine repeats was later confirmed by nano-
spray MS/MS and capLC/MS/MS analyses of samples that
had been subjected to reduction and permethylation. (The
glycans were reduced before permethylation to avoid the
peak splitting that would be introduced by resolution of
α- and β-anomers during chromatographic separations.)
Examples of the tandem mass spectra acquired during the
LC/MS analysis of the reduced and permethylated glycans
released by treatment of the intact LPG with endo-β-
galactosidase are provided in Fig. 4. Figure 4a shows the
CID MS/MS spectrum obtained for the glycan with [M +
Na]+ m/z 738.8 and Fig. 4b, the glycan with [M + Na]+ m/z
1,187.6. In contrast to PSD, CID-MS/MS produces some
cross-ring cleavages and thus furnishes information on the
linkages [48]. In the tandem mass spectrum shown in
Fig. 4, the 3,5A2 and
3,5A4 ions (B1 + 88 and B3 + 88,
respectively) indicate Hex1– 4HexNAc linkages, while the
absence of such an indicating ion suggests the presence of
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Fig. 2 FACE analysis and
predicted structure of
endo-β-galactosidase digest of
T. vaginalis LPG. Lane 1—total
digest; lane 8—standard glucose
oligomers. Bands B and A
(marked with arrows) from lane
1 were eluted and further
digested with exoglycosidases
shown in lanes 2–4 (band B) and
5–7 (band A)
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In addition to the poly-N-acetyllactosamine regions,
other segments of the LPG glycan structure contain few
amino-sugars but have multiple internal deoxyhexose
residues (most likely rhamnose, based upon HPAE-PAD
analysis). The compositions of the various components
observed in the MALDI-FTMS spectrum of the native LPG
glycans, present in such an acid-released fraction, are
assigned in Table 1. MALDI-FTMS SORI-CID analysis
of these LPG-derived oligosaccharides obtained after mild
(100 mM) TFA hydrolysis indicated the presence of
carbohydrates with a high content of deoxyhexose residues
(Table 1). A typical tandem MS spectrum, obtained for
[M + Na]+ m/z 960, is shown in Fig. 5. This spectrum is
consistent with the carbohydrate composition proposed on
the basis of the accurate mass measurement given in
Table 1, that assigns the peak at m/z 960.3578 to
HexNAc1dHex4Pent1 (calc. [M + Na]
+ m/z 960.3536).
From the observed fragments (Fig. 5) it is possible to
conclude that parallel losses of Pent(Xyl), HexNAc and
dHex(Rha) are indicative of a branched structure and
deoxyhexose residues are likely adjacent to one another.
Loss of 74 u likely results from 3,5X-type cleavage of a
HexNAc (or similar cleavage within a Pent residue).
Although there remains some ambiguity because of the
redundant compositions of fragments from candidate
structures, it is clear that extensive deoxyhexose residues
are present in the molecule. While it is possible that
rearrangements occur during fragmentation of native
oligosaccharides, it seems likely that isomeric structures
are present. Additional MSn experiments, as well as NMR
analyses, will be required to fully define all the potential
structures.
Structural nature of the CPI-glycan core domain
Mild acid treatment also released the native CPI-GC core
domain, which was isolated, treated and analysed as
described in “Materials and methods”. As elaborated below,
the native and the endo-β-galactosidase treated CPI-GC
moieties were largely responsible for chemokine production
in human genital tract epithelial cells.
The native CPI-GC domain showed a heterogeneous
band around 10–20 kDa when analyzed by SDS-PAGE
analysis and PAS staining [22]. When analyzed by
MALDI-TOF MS, the m/z 3,000–25,000 region of the
mass spectrum showed only a single high mass peak
centered at m/z 8,700 (Fig. 6). Compositional analysis of
CPI-GC by HPAE-PAD showed the presence of significant
amounts of Rha (25–30%), GlcN (38–43%), Gal (22–27%),
Xyl (4–8%) and small amounts of GalN (∼1% or less) and
Glc (1–2%).
The monosaccharide compositional analysis of the entire
CPI-GC fraction revealed large amounts of Gal, GlcN and
Rha, further suggesting the presence of lactosamine types
of saccharides in the CPI-GC molecule and the presence of
Rha residues outside of the lactosamine repeats. This is
consistent with the mass spectrometry data shown above.








Fig. 3 a MALDI-TOF mass spectrum of the glycans released from
TV LPG by endo-β-galactosidase. b PSD spectrum of the [M + Na]+
m/z 771 in the spectrum shown above. All fragments except some of
the peak centered at m/z 588 contain sodium. This peak likely contains
contributions from the B3(Na) fragment at m/z 587 and a C3(H)
fragment at m/z 591. c MALDI-TOF mass spectrum of the glycans
released from TV-LPG by endo-β-galactosidase, after subsequent
treatment with hexosaminidase
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contrast, treatment with β-galactosidase, N-acetyl-β-hexos-
aminidase, rhamnosidase, and xylosidase failed to release
any monosaccharides from native CPI-GC. After the native
CPI-GC fraction was treated with endo-β-galactosidase, the
released products were separated by C18-SepPak chroma-
tography into a saccharide fraction and post-enzymatic CPI-
GC. The released saccharide fraction was analyzed by
Glyko-FACE (Fig. 7). The saccharides ranged in size from
2–6 Glc units, suggesting the presence of N-acetyllactos-
amine repeats; similar to the results obtained above (Fig. 2).
B 
A Fig. 4 Quadrupole orthogonalTOF CID MS/MS spectra
obtained during a nanospray and
b capLC-nanospray MS analysis
of TV LPG-derived glycans
with a [M + Na]+ m/z 738.8, b
[M + Na]+ m/z 1,187.6. Putative
structures of the [M + Na]+ ions
are shown for these major com-
ponents from T. vaginalis LPG
that were analyzed after release
by endo-β-galactosidase or mild
acid hydrolysis, reduction and
permethylation. The component
whose spectrum is shown in a
was generated by both enzy-
matic and acid release; the
component in b appeared in
only the acid-released fractions
Fig. 5 SORI-CID mass spectrum obtained for the [M + Na]+ m/z 960
in the MALDI-FTMS spectrum of oligosaccharides that were released
from TV LPG by mild acid hydrolysis (outer branch saccharide).
Compositions are indicated as dH, deoxyhexose; N, N-acetylhexos-
amine; P, pentose. Ions marked with an apostrophe (’) are B- (or Z)-
type ions, the rest are Y- (or C)-type ions; loss of 74 u most likely
originates through elimination of CHOHCHCH2OH from a nonreduc-
ing HexNAc (or Pent) terminus of the intact glycan or cleavage of an
internal HexNAc residue that has 1,4-linkage, to form the 3,5Xn-series.
Low m/z ions are internal ions. All ions contain Na
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Functional analysis of LPG fragments and CPI-glycan core
domains
To determine the biological role(s) and relative importance
of the outer branch saccharides and the CPI-GC domains in
the pathogenic epithelial responses to trichomoniasis, we
compared LPG and fractions released by periodate, mild
acid (TFA), endo-β-galactosidase and PI-PLC (see Fig. 1)
to a nontoxic biologically active dose of the proinflamma-
tory cytokine IL-1β (25 ng/mL) and to infection with live
trichomonads.
The effects on epithelial cell viability following
24-h exposure to various LPG sub-domains and intact LPG
were assessed as percent survival rates versus untreated cell
cultures (Fig. 8). IL-8 production was measured in the cell
culture supernatants in parallel to the MTT viability assays
(Fig. 9). Intact LPG was nontoxic to both vaginal and
endocervical epithelial cells at doses <250 μg/mL and at
the same time significantly increased IL-8 production in a
Table 1 FTMS analysis of
native TV-LPG glycans from
an acid-released fraction
a The composition of m/z
960.3578 was confirmed by the
SORI-CID MS/MS analysis
shown in Fig. 5
m/z obs m/z cal Composition
HexNAc Hex DeoxyHex Pent Na
668.2396 668.2378 1 2 1 1
682.2558 682.2534 1 3 1
814.2988 814.2957 1 3 1 1
828.3138 828.3113 1 4 1
960.3578a 960.3536 1 4 1 1
974.3745 974.3693 1 5 1
1,031.3954 1,031.3907 2 4 1
1,106.4177 1,106.4115 1 5 1 1
1,163.4399 1,163.4330 2 4 1 1
1,177.4550 1,177.4486 2 5 1
1,238.4660 1,238.4538 1 5 2 1
1,252.4742 1,252.4694 1 6 1 1
1,268.4706 1,268.4643 1 1 5 1 1
1,295.4867 1,295.4752 2 4 2 1
1,309.4997 1,309.4909 2 5 1 1
1,323.5140 1,323.5065 2 6 1
1,325.4916 1,325.4858 2 1 4 1 1
1,366.5244 1,366.5123 3 4 1 1
1,398.5367 1,398.5273 1 7 1 1
1,441.5433 1,441.5331 2 5 2 1
1,455.5592 1,455.5488 2 6 1 1
1,469.5767 1,469.5644 2 7 1
1,471.5509 1,471.5437 2 1 5 1 1
1,512.5827 1,512.5703 3 5 1 1
1,601.6171 1,601.6067 2 7 1 1
1,644.6239 1,644.6125 3 5 2 1
1,658.6481 1,658.6282 3 6 1 1
1,733.6598 1,733.6490 2 7 2 1
1,747.6743 1,747.6646 2 8 1 1
1,804.7018 1,804.6861 3 7 1 1
1,806.7003 1,806.6653 3 1 5 2 1
1,865.6970 1,865.6912 2 7 3 1
Fig. 6 MALDI-TOF mass spectrum of the CPI-GC released by mild
acid treatment of the TV-LPG, plotted over the range m/z 3,000–
25,000
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dose-dependent manner (Figs. 8a–b and 9a). Periodate
treated LPG was nontoxic even at higher doses (>500 μg/mL)
(Fig. 8a–b) and completely lost its proinflammatory proper-
ties (Fig. 9a). The native CPI-GC fraction was as active as
intact LPG. IL-8 production was induced by nontoxic doses
of LPG and CPI-GC estimated to be the equivalent of ∼4–
10 parasites per epithelial cell (Fig. 9a–b). In contrast, the
outer branch fraction, and the PI-PLC-released saccharide-
I-P (see Fig. 1) were biologically inert (Figs. 8a–b and 9a).
Also, inositol-P-ceramide (CPI) isolated from T. vaginalis
(24) failed to show any biological activity (data not shown).
The saccharide fraction released from native CPI-GC by
endo-β-galactosidase had no biological activity but the
remaining post-enzymatic CPI-GC fraction had strong
proinflammatory activity (Figs. 8c and 9b). The biological
specificity of this reaction was confirmed by the lack of
IL-8 induction by equivalent doses of native CPI-GC from
the bovine trichomonad and by the ethanol diluent (EtOH).
Intact LPG and the CPI-GC fractions induced IL-8 produc-
tion commensurate with that induced by a high dose
recombinant IL-1β (Fig. 9a–b).
The intact LPG molecule and the native CPI-GC fraction
induced NF-κB activation comparable in magnitude to that
induced by estimated equivalent load of live T. vaginalis
(∼5–10 parasites per epithelial cell) (Fig. 10a) and rapid
(30–120 min) phosphorylation of NF-κB p65 subunit at
Ser536 (Fig. 10b). Within 30 min of stimulation, the intact
LPG and CPI-GC induced phosphorylation of MEK1/2
kinase (Fig. 10c) and within 1 h—pERK1/2 (Fig. 10d).
Levels of total ERK and MEK1/2 remained unchanged
(data not shown). Neither the saccharide fractions nor the
bovine CPI-GC induced MEK1/2, NF-κB or ERK activa-
tion (data not shown).
Discussion
This study is the first to demonstrate that T. vaginalis LPG
contains poly-N-acetyllactosamine (Galβ1–4 GlcNAcβ1–3
Galβ1–4GlcNAc) repeats and the first to reveal the relative
biological significance of various LPG domains in triggering
inflammatory cascades in vaginal epithelial cells.






















































Fig. 8 Effects of LPG fractions on epithelial cell viability measured
by MTT assay. Endocervical (a) and vaginal (b and c) epithelial cells
were exposed for 24 h to intact LPG or various LPG fragments and
CPI-GC obtained after treatment with periodate, mild acid (TFA) or
CPI-PLC (a and b). The CPI-GC and saccharide fractions shown in c
were obtained after endo-β-galactosidase treatment of the native CPI-
GC. Stock solutions of lyophilized lipid fractions were prepared in
PBS/ethanol (EtOH) and of saccharide fractions in PBS. Recombinant
human (rh) IL-1β served as positive control. Horizontal axes present
two-fold serial dilutions of LPG and fractions at equivalent concen-
trations. Bars represent means and SEM from triplicate cultures in one








Fig. 7 FACE Analysis of endo-β-galactosidase treated CPI-GC. The
CPI-GC was treated with endo-β-galactosidase for 18 h and the
released saccharides were purified by C18 Sep-Pak and derivatized
with ANTS for FACE analysis. Lane 1—standard glucose oligomers;
lane 2—CPI-GC digest
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Several bioanalytical techniques such as enzymatic
digestion, FACE, MS and tandem MS analyses were
employed to derive the lactosamine structures in LPG and
its CPI-GC core. The sensitivity of LPG and native CPI-GC
to endo-β-galactosidase digestion, with the production of
oligosaccharides that could be further digested with β-N-
acetylhexosaminidase and β-galactosidase, was consistent
with the presence of lactosamine repeats in the outer
saccharide branch. Furthermore, the fragmentation patterns
obtained in mass spectral analyses confirmed the results of the
enzymatic digestions. The identity of terminal Gal and GlcN
was derived from enzymatic, HPAE-PAD, and FACE
analyses. In addition, the CPI-GC domain derived from native
CPI-GC by endo-β-galactosidase treatment (see Fig. 7) may
retain some of the poly-N-acetyllactosamine-type structures.
The poly-N-acetyllactosamine structures are unique in a
lipid-linked phosphoinositol-anchored molecule. It is of
interest to note that all reported GPI-molecules have a
glycan core containing the sequence Manα1–4GlcNα1-Ino
[49] but T. vaginalis LPG contains no Man residues. In the
past, Dionex chromatographic program was used to separate
monosaccharides by the PA1 column which did not
adequately separate Man from Xyl and the observed peak
was attributed to the presence of Man (not Xyl), since this
monosaccharide would have been expected for a molecule
containing a GPI anchor. However, we later determined by
two different methods (GC/MS and HPAE-PAD) that LPG
does not contain Man, but rather it contains Xyl [22, 27].
T. vaginalis LPG and its CPI-GC appear to be unique
surface glycolipids in that they express certain features
of a prokaryotic glycoconjugate, e.g. large amounts of
rhamnose. Even though T. vaginalis is a eukaryote, LPG is
not anchored to the parasite surface by a conserved
eukaryotic GPI-anchored molecule. Another important dis-
covery is the presence of significant amounts of Rha, Gal
and GlcN along with Xyl in the LPG and the CPI-GC core.
The presence of Rha and Xyl in each fraction (mild acid
derived saccharides and CPI-GC) hindered the acquisition
of glycosidase-based oligosaccharide sequence information.
Rhamnosidase and xylosidase were unable to release
Rha/Xyl, which suggests that the Rha and Xyl residues
are not terminal and/or they do not have linkages that are
susceptible to the available glycosidase enzymes. The
limited ability of β-galactosidase and β-N-acetylhexosa-
minidase to release monosaccharides may be due to the
presence of Rha and Xyl in each fraction and the presence
of branches. This conclusion is supported by MS analysis,
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upregulation of IL-8 after 24 h
stimulation of vaginal epithelial
cells with intact T. vaginalis
LPG and various LPG fractions
in two-fold serial dilutions.
Controls included the diluents
PBS and PBS/ethanol (EtOH),
T. foetus (TF) LPG CPI-GC,
live T. vaginalis (four to ten
parasite per epithelial cell) and
recombinant human IL-1β. Bars
represent the mean and SEM of
duplicate cultures in one of two
experiments performed with
each set of fractions (a and b)
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residues (Rha based on monosaccharide analysis) in the
backbone of the LPG molecule and pentose branches.
These residues appear to be located outside of the regions
containing N-acetyllactosamine repeats and may block
β-galactosidase and β-N-acetylhexosaminidase digestion.
Determination of the detailed structures of these branched
regions will require higher order MS analyses, in combina-
tion with NMR studies.
The discovery of poly-N-acetyllactosamine repeats in
LPG and CPI-GC opens interesting possibilities for novel
LPG–host interactions. For example, LPG and its CPI-GC
core may serve as ligands for β-galactoside-binding lectins
such as various members of the galectin family. Galectins
are expressed in several cell types, including epithelial
cells, and are known to play vital roles in host-pathogen
interactions and immune recognition [50–52]. In fact, our
recent data suggest that galectin-1 and -3 are expressed in
the human ectocervical, endocervical and vaginal epithelial
cells used in our experimental systems [53].
We showed earlier that T. vaginalis LPG is the
predominant molecule anchored to the parasite surface
[23, 24]. It is highly glycosylated, contains a lipid-linked
phosphoinositol-type anchor [22, 23] and that it plays a
significant role in the parasite adhesion and proinflamma-
tory activation of epithelial cells originating from the three
anatomic regions of the human lower female genital tract—
endocervical, ectocervical and vaginal [22]. We showed
that LPG induced a marked dose-dependent upregulation of
the chemokines IL-8 and MIP-3α and a moderate increase
of the cytokine IL-6 in a dose-dependent and species-
specific manner, whereas IL-1β and TNFα levels in the
same cultures remained at baseline. It is important to note
that these cells are deficient in the molecular machinery for
bacterial endotoxin responses [37], which, along with the
lack of bacterial contamination confirmed by endotoxin-
negative testing of the purified LPG and fractions, suggests
specific novel pathways of LPG signaling different from
that utilized by bacterial LPS.
The results presented here clearly demonstrate a key role
for the CPI-GC core of LPG in triggering inflammatory
cascades in cervicovaginal epithelial cells. Importantly, LPG
from the bovine parasite T. foetus showed no effect on
cytokine production; this result demonstrates the species
specificity of the cytokine and chemokine triggering mech-
anisms. Clearly, both the intact and the endo-β-galactosidase
treated CPI-GC moiety from T. vaginalis are capable of
activation of the major proinflammatory nuclear transcription
factor NF-κB and production of IL-8. No other saccharide
fraction had this effect. Multiple proinflammatory stimuli,
e.g. endogenous cytokines, bacterial, viral and eukaryotic
pathogens, activate NF-κB via a series of phosphorylation
events. These events include its dissociation from the
cytoplasmic inhibitor IκB and translocation to the nucleus,
where NF-kB cooperates with other factors to transactivate a
myriad of proinflammatory genes including IL-8 [54].
IL-8 is the most powerful chemoattractant for neutrophils
and macrophages and its presence in the vaginal discharge is
indicative of acute and chronic inflammatory conditions of
the lower female genital tract [55–57]. In addition, IL-8 may
be directly linked to increased HIV-1 replication and
transmission in the genital tract mucosa [58, 59] and thus
represents one possible mechanism for the increased HIV
transmission incidence in women with trichomoniasis.
LPG and CPI-GC elicited phosphorylation of the NF-κB
p65 subunit at Ser536. This phosphorylation event occurs









































































































































Fig. 10 Activation of NF-κB and ERK1/2 in endocervical (a) and
vaginal (b–c) epithelial cells. Endocervical epithelial cell line stably
transfected with pNF-κB lucifearse reporter (a) was exposed to intact
TV and TF LPG, equivalent dose of native TV CPI-GC fraction and
live T. vaginalis (four to ten parasite per epithelial cell), and rhIL-1β
(25 ng/mL) for 24 h. Bars represent the means and SEM of luciferase
activity in relative luminescent units (RLU) measured in triplicate
cultures in two experiments. Vaginal epithelial cells were assessed for
pNF-κB ser536 b at 2 h, pMEK1/2 c at 30 min and pERK1/2 d at 1 h
post stimulation with TV LPG or equivalent dose (60 μg/mL) of
CPI-GC. Bars represent means + SD from triplicate cultures in two
experiments
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and serves to slow down its export from the nucleus back to
the cytosol, thus increasing the amplitude of NF-κB-
induced gene transactivation. Ser536 phosphorylation also
promotes NF-κB mediated transcription via recruitment of
other transcription coactivators such as p300, enlarging the
scope of proinflammatory activities [60]. LPG and CPI-GC
also induced phosphorylation of ERK1/2, which is activated
in macrophages upon trichomonad infection and linked to
host cell apoptosis [61]. This is consistent with our findings
that CPI-GC core (and not the outer branch saccharides)
is responsible for the reduction of human vaginal and
cervical cell viability.
Here we also demonstrate for the first time that T. vaginalis
LPG signaling may be mediated by MEK1/2 phosphoryla-
tion. MEK1/2 has been implicated in the activation of the
ERK family of protein kinases [62] and thus these data are
in agreement with the downstream activation of ERK1/2
observed in response to LPG and CPI-GC.
Conclusions
The results presented in this paper suggest that, similar to
the lipid A of LPS from Gram negative bacteria, the CPI-GC
moiety of T. vaginalis LPG is important in regulating the
host inflammatory response. In the context of normal human
cervicovaginal epithelial cells, the immunoinflammatory
activation appears to occur in the absence of the dominant
LPS-responsive molecular machinery, including TLR4,
MD2 and CD14. The loss of proinflammatory activity
following periodate and PI-PLC treatments of LPG suggests
the importance of both the lipid and glycan components of
the CPI-GC in epithelial cell receptor binding initiating
signaling cascades and downstream pathogenic responses.
While the host receptors for any of the T. vaginalis surface
structures are still unknown, the discovery of poly-N-
acetyllactosamine repeats in LPG and CPI-GC opens the
possibilities for interaction with the host galactoside binding
lectins. Studies on pattern recognition receptors for LPG
and its CPI-GC are underway to further define the role of
T. vaginalis in mucosal immune regulation.
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